BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M. Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account. PLoS One. 2016;11:e0156666. [PMID: 27332879 DOI: 10.1371/journal.pone.0156666] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Regev S, Schwartz D, Sarid O, Goren G, Slonim-Nevo V, Friger M, Sergienko R, Greenberg D, Monsonego A, Nemirovsky A, Odes S. Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease. Aliment Pharmacol Ther 2023. [PMID: 36734040 DOI: 10.1111/apt.17399] [Reference Citation Analysis]
2 Han SJ, Kang EA, Park J, Park SJ, Park JJ, Kim TI, Kim WH, Cheon JH. Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy. Yonsei Med J 2023;64:111-6. [PMID: 36719018 DOI: 10.3349/ymj.2022.0264] [Reference Citation Analysis]
3 Salwen-deremer JK, Ballou S. Painful GI Conditions and Their Bidirectional Relationships with Sleep Disturbances. Curr Sleep Medicine Rep. [DOI: 10.1007/s40675-022-00230-9] [Reference Citation Analysis]
4 Tripp DA, Walker S, Moreau J, Jones K, Ropeleski MJ, Beyak M. Patient-Reported Pain Distributions in Inflammatory Bowel Disease: Impact on Patient Psychosocial Outcomes. Gastroenterology Nursing 2022;Publish Ahead of Print. [DOI: 10.1097/sga.0000000000000684] [Reference Citation Analysis]
5 Mas-orea X, Maurel S, Dietrich G. Régulation de la douleur inflammatoire viscérale par les opioïdes d’origine lymphocytaire. Douleur analg 2022;35:144-152. [DOI: 10.3166/dea-2022-0223] [Reference Citation Analysis]
6 Alavinejad P, Nayebi M, Parsi A, Farsi F, Maghool F, Alipour Z, Alimadadi M, Ahmed MH, Cheraghian B, Hang DV, Shahrokh S, Emami MH, Hashemi SJ, Alboraie M, Dehnavi D, Riazi M, Seyedian SS, Emara MH, Lenz L, Tran QT, Shahinzadeh S, Daryani NE, Hajiani E, Moghaddam EK, Shahi MM, Rezvanifar M, Azimi T. IS DAIRY FOODS RESTRICTION MANDATORY FOR INFLAMMATORY BOWEL DISEASE PATIENTS: A MULTINATIONAL CROSS-SECTIONAL STUDY. Arq Gastroenterol 2022;59:358-364. [DOI: 10.1590/s0004-2803.202203000-65] [Reference Citation Analysis]
7 Schöler D, Kostev K, Peters M, Zamfir C, Wolk A, Roderburg C, Loosen SH. Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel Disease. J Clin Med 2022;11:4586. [PMID: 35956201 DOI: 10.3390/jcm11154586] [Reference Citation Analysis]
8 Rabinowitz LG, Zylberberg HM, Yang J, Gold SL, Chesner J, Ji J, Hu L, Dubinsky M. De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease. Dig Dis Sci 2022;67:4033-42. [PMID: 34613501 DOI: 10.1007/s10620-021-07257-y] [Reference Citation Analysis]
9 Wils P, Caron B, D’amico F, Danese S, Peyrin-biroulet L. Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge. JCM 2022;11:4269. [DOI: 10.3390/jcm11154269] [Reference Citation Analysis]
10 Falling CL, Siegel CA, Salwen-deremer JK. Inflammatory Bowel Disease and Pain Interference: A Conceptual Model for the Role of Insomnia, Fatigue, and Pain Catastrophizing. Crohn's & Colitis 360 2022;4. [DOI: 10.1093/crocol/otac028] [Reference Citation Analysis]
11 Salwen-Deremer JK, Smith MT, Haskell HG, Schreyer C, Siegel CA. Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders. Dig Dis Sci 2022;67:3096-107. [PMID: 34331174 DOI: 10.1007/s10620-021-07176-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Bogale K, Maheshwari P, Kang M, Gorrepati VS, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K, Coates MD. Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease. Sci Rep 2022;12:10577. [PMID: 35732802 DOI: 10.1038/s41598-022-14838-y] [Reference Citation Analysis]
13 Rodríguez-lago I, Mesonero F, Hijos-mallada G, Cañas M, Saldaña R, Savini C, Fernández S, Juliá B, Cea-calvo L. Self-medication with analgesics reported by patients with ulcerative colitis: An anonymous survey. Gastroenterología y Hepatología (English Edition) 2022;45:457-463. [DOI: 10.1016/j.gastre.2021.07.005] [Reference Citation Analysis]
14 Falling CL, Stebbings S, David Baxter G, Siegel CA, Gearry RB, Mani R. Somatosensory assessments in patients with inflammatory bowel disease: a cross-sectional study examining pain processing pathways and the role of multiple patient factors. Eur J Gastroenterol Hepatol 2022;34:503-11. [PMID: 35170531 DOI: 10.1097/MEG.0000000000002354] [Reference Citation Analysis]
15 Lee KM, Sherlock JP, Hamilton JA. The role of interleukin (IL)-23 in regulating pain in arthritis. Arthritis Res Ther 2022;24:89. [PMID: 35468842 DOI: 10.1186/s13075-022-02777-y] [Reference Citation Analysis]
16 Prasad SS, Walker MM, Talley NJ, Keely S, Kairuz T, Jones MP, Duncanson K. Healthcare Needs and Perceptions of People Living With Inflammatory Bowel Disease in Australia: A Mixed-Methods Study. Crohn's & Colitis 360 2022;4. [DOI: 10.1093/crocol/otab084] [Reference Citation Analysis]
17 Fawson S, Dibley L, Smith K, Batista J, Artom M, Windgassen S, Syred J, Moss-Morris R, Norton C. Developing an Online Program for Self-Management of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Patients' Needs and Wants. Dig Dis Sci 2022;67:2813-26. [PMID: 34146202 DOI: 10.1007/s10620-021-07109-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ghahramani S, Tamartash Z, Sayari M, Vahedi H, Karimian F, Heydari S, Bagheri Lankarani K. Risk Factors Affecting 90-day Readmission of Patients with Inflammatory Bowel Disease. Middle East J Dig Dis 2022;14:34-43. [PMID: 36619729 DOI: 10.34172/mejdd.2022.253] [Reference Citation Analysis]
19 Shafer LA, Sofia MA, Rubin DT, Steinhart AH, Ng SC, Reches L, Israeli E, Bernstein CN. An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI. Clin Gastroenterol Hepatol 2021;19:2524-31. [PMID: 32858200 DOI: 10.1016/j.cgh.2020.08.053] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Kuźnicki P, Neubauer K. Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse. J Clin Med 2021;10:4623. [PMID: 34640641 DOI: 10.3390/jcm10194623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology 2021;161:1118-32. [PMID: 34358489 DOI: 10.1053/j.gastro.2021.07.042] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 32.5] [Reference Citation Analysis]
22 Bakshi N, Hart AL, Lee MC, Williams ACC, Lackner JM, Norton C, Croft P. Chronic pain in patients with inflammatory bowel disease. Pain 2021;162:2466-71. [PMID: 34534174 DOI: 10.1097/j.pain.0000000000002304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Takahashi K, Khwaja IG, Schreyer JR, Bulmer D, Peiris M, Terai S, Aziz Q. Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab073] [Reference Citation Analysis]
24 Sange AH, Srinivas N, Sarnaik MK, Modi S, Pisipati Y, Vaidya S, Syed Gaggatur N, Sange I. Extra-Intestinal Manifestations of Inflammatory Bowel Disease. Cureus 2021;13:e17187. [PMID: 34548984 DOI: 10.7759/cureus.17187] [Reference Citation Analysis]
25 Rodríguez-Lago I, Mesonero F, Hijos-Mallada G, Cañas M, Saldaña R, Savini C, Fernández S, Juliá B, Cea-Calvo L; ACCU, GETECCU, GETEII. Self-medication with analgesics reported by patients with ulcerative colitis: An anonymous survey. Gastroenterol Hepatol 2021:S0210-5705(21)00227-2. [PMID: 34400189 DOI: 10.1016/j.gastrohep.2021.07.009] [Reference Citation Analysis]
26 Ewais T, Begun J, Kenny M, Hay K, Houldin E, Chuang KH, Tefay M, Kisely S. Mindfulness based cognitive therapy for youth with inflammatory bowel disease and depression - Findings from a pilot randomised controlled trial. J Psychosom Res 2021;149:110594. [PMID: 34399198 DOI: 10.1016/j.jpsychores.2021.110594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bakshi N, Berry S, Aziz Q, Glatter J. The challenge of treating chronic pain in inflammatory bowel disease. British Journal of Healthcare Management 2021;27:182-184. [DOI: 10.12968/bjhc.2021.0086] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Dawwas GK, Jajeh H, Shan M, Naegeli AN, Hunter T, Lewis JD. Prevalence and Factors Associated With Fecal Urgency Among Patients With Ulcerative Colitis and Crohn’s Disease in the Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease. Crohn's & Colitis 360 2021;3:otab046. [DOI: 10.1093/crocol/otab046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
29 Hurtado-lorenzo A, Honig G, Weaver SA, Larkin PB, Heller C. Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize Treatment and Improve Clinical Outcomes. Crohn's & Colitis 360 2021;3:otab034. [DOI: 10.1093/crocol/otab034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 West C, McVey Neufeld KA. Animal models of visceral pain and the role of the microbiome. Neurobiol Pain 2021;10:100064. [PMID: 34151049 DOI: 10.1016/j.ynpai.2021.100064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Kuenzig ME, Manuel DG, Donelle J, Benchimol EI. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease. CMAJ 2020;192:E1394-402. [PMID: 33168761 DOI: 10.1503/cmaj.190976] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
32 Falling C, Stebbings S, Baxter GD, Gearry RB, Mani R. Criterion validity and discriminatory ability of the central sensitization inventory short form in individuals with inflammatory bowel diseases. Scand J Pain 2021;21:577-85. [PMID: 34015864 DOI: 10.1515/sjpain-2021-0021] [Reference Citation Analysis]
33 Niccum B, Moninuola O, Miller K, Khalili H. Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2021;19:895-907.e4. [PMID: 32835841 DOI: 10.1016/j.cgh.2020.08.041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
34 Ziadé N, El Hajj J, Rassi J, Hlais S, Lopez-Medina C, Gamal SM, Elzorkany B, Dougados M, Baraliakos X. Root Joint Involvement in Spondyloarthritis: A Post-hoc Analysis from the International ASAS-PerSpA Study. Rheumatology (Oxford) 2021:keab380. [PMID: 33905488 DOI: 10.1093/rheumatology/keab380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Szigethy EM, Murphy SM, Ehrlich OG, Heller CA, Engel-nitz NM, Meadows P, Allen JI. Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab021] [Reference Citation Analysis]
36 Meunier A, Sorce G, Hardy PY, Coimbra C, Decker E, Joris J. Comparison of outcome after right colectomy with an enhanced recovery programme in patients with inflammatory bowel disease and patients operated on for other conditions: a monocentric retrospective study. Int J Colorectal Dis 2021;36:757-63. [PMID: 33423143 DOI: 10.1007/s00384-020-03830-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 MacDonald TM, Fisk JD, Bernstein CN, El-Gabalawy R, Hitchon CA, Kornelsen J, Patten SB, Tisseverasinghe A, Marrie RA. The association between childhood maltreatment and pain catastrophizing in individuals with immune-mediated inflammatory diseases. J Psychosom Res 2021;145:110479. [PMID: 33814193 DOI: 10.1016/j.jpsychores.2021.110479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Ledergerber M, Lang BM, Heinrich H, Biedermann L, Begré S, Zeitz J, Krupka N, Rickenbacher A, Turina M, Greuter T, Schreiner P, Roth R, Siebenhüner A, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management. BMC Gastroenterol 2021;21:53. [PMID: 33546600 DOI: 10.1186/s12876-021-01622-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
39 Lashgari NA, Roudsari NM, Zandi N, Pazoki B, Rezaei A, Hashemi M, Momtaz S, Rahimi R, Shayan M, Dehpour AR, Abdolghaffari AH. Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations. Mol Biol Rep 2021;48:855-74. [PMID: 33394234 DOI: 10.1007/s11033-020-06095-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
40 Yacyshyn BR, Hanauer S, Klassen P, English BA, Stauber K, Barish CF, Gilder K, Turner S, Higgins PDR. Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn’s Disease. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otaa089] [Reference Citation Analysis]
41 Coates MD, Johri A, Gorrepati VS, Maheshwari P, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K. Abdominal pain in quiescent inflammatory bowel disease. Int J Colorectal Dis 2021;36:93-102. [PMID: 32879990 DOI: 10.1007/s00384-020-03727-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Hisamatsu T, Suzuki Y, Kobayashi M, Hagiwara T, Kawaberi T, Ogata H, Matsui T, Watanabe M, Hibi T. Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn's disease: 3-year results from a real-world study. Intest Res 2021;19:408-18. [PMID: 33207857 DOI: 10.5217/ir.2020.00025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
43 Kienzl M, Storr M, Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin Transl Gastroenterol 2020;11:e00120. [PMID: 31899693 DOI: 10.14309/ctg.0000000000000120] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
44 Ewais T, Begun J, Kenny M, Headey A, Tefay M, Kisely S. Mindfulness-based cognitive therapy experiences in youth with inflammatory bowel disease and depression: findings from a mixed methods qualitative study. BMJ Open 2020;10:e041140. [PMID: 33148766 DOI: 10.1136/bmjopen-2020-041140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Falling C, Stebbings S, Baxter GD, Siegel CA, Gearry RB, Nijs J, Mani R. Symptoms of central sensitization in patients with inflammatory bowel diseases: a case-control study examining the role of musculoskeletal pain and psychological factors. Scand J Pain 2021;21:283-95. [PMID: 34387957 DOI: 10.1515/sjpain-2020-0109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Pettersson N, Kragsbjerg F, Hamrin A, Bergman S, Forsblad-d'Elia H, Karling P. Increased chronic pain in patients with ulcerative colitis is mostly associated to increased disease activity. A cross-sectional case-control study. Scand J Gastroenterol 2020;55:1193-9. [PMID: 32946699 DOI: 10.1080/00365521.2020.1820567] [Reference Citation Analysis]
47 Morrison R, Jesdale B, Dube C, Forrester S, Nunes A, Bova C, Lapane KL. Racial/Ethnic Differences in Staff-Assessed Pain Behaviors Among Newly Admitted Nursing Home Residents. J Pain Symptom Manage 2021;61:438-448.e3. [PMID: 32882357 DOI: 10.1016/j.jpainsymman.2020.08.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
48 Salwen-deremer JK, Siegel CA, Smith MT. Cognitive Behavioral Therapy for Insomnia: A Promising Treatment for Insomnia, Pain, and Depression in Patients With IBD. Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otaa052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Antonioli L, Lucarini E, Lambertucci C, Fornai M, Pellegrini C, Benvenuti L, Di Cesare Mannelli L, Spinaci A, Marucci G, Blandizzi C, Ghelardini C, Volpini R, Dal Ben D. The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis. Cells 2020;9:E1509. [PMID: 32575844 DOI: 10.3390/cells9061509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
50 Berry SK, Takakura W, Bresee C, Melmed GY. Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization. Dig Dis Sci 2020;65:1777-83. [PMID: 31654314 DOI: 10.1007/s10620-019-05906-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
51 Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res 2020;18:249-64. [PMID: 32295331 DOI: 10.5217/ir.2019.00128] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
52 Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
53 Mikocka-Walus A, Ford AC, Drossman DA. Antidepressants in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:184-92. [PMID: 32071420 DOI: 10.1038/s41575-019-0259-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
54 Sweeney L, Moss-Morris R, Czuber-Dochan W, Murrells T, Norton C. Developing a better biopsychosocial understanding of pain in inflammatory bowel disease: a cross-sectional study. Eur J Gastroenterol Hepatol 2020;32:335-44. [PMID: 31851083 DOI: 10.1097/MEG.0000000000001615] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
55 Carbone SE, Poole DP. Inflammation without pain: Immune-derived opioids hold the key. Neurogastroenterol Motil 2020;32:e13787. [PMID: 31999404 DOI: 10.1111/nmo.13787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
56 Salwen-deremer JK, Speed BC. Comment on: Incidence of Adverse Psychiatric Events During the Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review. Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otz051] [Reference Citation Analysis]
57 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 842] [Cited by in F6Publishing: 825] [Article Influence: 210.5] [Reference Citation Analysis]
58 Sonnenberg E, Biedermann L. Chronische Schmerzen und Fatigue bei chronisch-entzündlichen Darmerkrankungen. Gastroenterologe 2019;14:441-450. [DOI: 10.1007/s11377-019-00389-8] [Reference Citation Analysis]
59 Coates MD, Soriano C, Dalessio S, Stuart A, Walter V, Koltun W, Bernasko N, Tinsley A, Clarke K, Williams ED. Gastrointestinal hypoalgesia in inflammatory bowel disease. Ann Gastroenterol 2020;33:45-52. [PMID: 31892797 DOI: 10.20524/aog.2019.0442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
60 Alley K, Singla A, Afzali A. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1990-5. [PMID: 31087042 DOI: 10.1093/ibd/izz100] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
61 Falling CL, Stebbings S, Baxter DG, Gearry RB, Mani R. Central Sensitization Inventory Mediates the Relationship Between Inflammatory Bowel Disease Activity and Worse Musculoskeletal Pain Experiences. Pain Pract 2019;20:24-33. [DOI: 10.1111/papr.12821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
62 Falling C, Stebbings S, Baxter GD, Gearry RB, Mani R. Musculoskeletal Pain in Individuals With Inflammatory Bowel Disease Reflects Three Distinct Profiles. The Clinical Journal of Pain 2019;35:559-68. [DOI: 10.1097/ajp.0000000000000698] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
63 López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain. Behav Pharmacol 2018;29:120-39. [PMID: 29543647 DOI: 10.1097/FBP.0000000000000386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
64 Falling C, Stebbings S, Baxter GD, Mani R. Central hypersensitivity - A model for persistent musculoskeletal pain in inflammatory bowel diseases. Med Hypotheses 2019;129:109243. [PMID: 31371091 DOI: 10.1016/j.mehy.2019.109243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
65 Robertson N, Gunn S, Piper R. Psychological and Social Factors Associated with Pain in Inflammatory Bowel Disease: A Systematic Literature Review of the Evidence in Adult and Pediatric Studies. Crohn's & Colitis 360 2019;1. [DOI: 10.1093/crocol/otz003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, Scharl M, Greuter T, Schreiner P, Frei P, Misselwitz B, Biedermann L, Zeitz J; Swiss IBD Cohort Study Group. Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study. PLoS One 2019;14:e0215738. [PMID: 31022217 DOI: 10.1371/journal.pone.0215738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Picard E, Carvalho FA, Agosti F, Bourinet E, Ardid D, Eschalier A, Daulhac L, Mallet C. Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation. Br J Pharmacol 2019;176:950-63. [PMID: 30714145 DOI: 10.1111/bph.14608] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
68 Falling C, Stebbings S, Baxter GD, Gearry RB, Mani R. Profile of musculoskeletal pain in patients with inflammatory bowel disease: a study protocol for assessing the multidimensional experience of self-reported pain. Physical Therapy Reviews 2018;23:227-35. [DOI: 10.1080/10833196.2018.1500149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
69 Zhang D, Ren YB, Wei K, Hong J, Yang YT, Wu LJ, Zhang J, Shi Z, Wu HG, Ma XP. Herb-partitioned moxibustion alleviates colon injuries in ulcerative colitis rats. World J Gastroenterol 2018; 24(30): 3384-3397 [PMID: 30122878 DOI: 10.3748/wjg.v24.i30.3384] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
70 Mack DS, Hunnicutt JN, Jesdale BM, Lapane KL. Non-Hispanic Black-White disparities in pain and pain management among newly admitted nursing home residents with cancer. J Pain Res 2018;11:753-61. [PMID: 29695927 DOI: 10.2147/JPR.S158128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
71 Sweeney L, Moss-Morris R, Czuber-Dochan W, Meade L, Chumbley G, Norton C. Systematic review: psychosocial factors associated with pain in inflammatory bowel disease. Aliment Pharmacol Ther 2018;47:715-29. [PMID: 29359343 DOI: 10.1111/apt.14493] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
72 Aguirre JE, Winston JH, Sarna SK. Neonatal immune challenge followed by adult immune challenge induces epigenetic-susceptibility to aggravated visceral hypersensitivity. Neurogastroenterol Motil 2017;29. [PMID: 28439935 DOI: 10.1111/nmo.13081] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
73 Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, Dallel R, Guttmann A, Clavelou P, Buisson A. Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study. Eur J Pain 2017;21:1550-60. [DOI: 10.1002/ejp.1056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
74 Zeitz J, Bissig M, Barthel C, Biedermann L, Scharl S, Pohl D, Frei P, Vavricka SR, Fried M, Rogler G, Scharl M. Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease? Eur J Gastroenterol Hepatol 2017;29:322-30. [PMID: 27879485 DOI: 10.1097/MEG.0000000000000783] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
75 Odes S, Friger M, Sergienko R, Schwartz D, Sarid O, Slonim-Nevo V, Singer T, Chernin E, Vardi H, Greenberg D, Israel IBD Research Nucleus. Simple pain measures reveal psycho-social pathology in patients with Crohn’s disease. World J Gastroenterol 2017; 23(6): 1076-1089 [PMID: 28246482 DOI: 10.3748/wjg.v23.i6.1076] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]